BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 30620189)

  • 1. Cellular-Based Selections Aid Yeast-Display Discovery of Genuine Cell-Binding Ligands: Targeting Oncology Vascular Biomarker CD276.
    Stern LA; Lown PS; Kobe AC; Abou-Elkacem L; Willmann JK; Hackel BJ
    ACS Comb Sci; 2019 Mar; 21(3):207-222. PubMed ID: 30620189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geometry and expression enhance enrichment of functional yeast-displayed ligands via cell panning.
    Stern LA; Schrack IA; Johnson SM; Deshpande A; Bennett NR; Harasymiw LA; Gardner MK; Hackel BJ
    Biotechnol Bioeng; 2016 Nov; 113(11):2328-41. PubMed ID: 27144954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic Bead-Immobilized Mammalian Cells Are Effective Targets to Enrich Ligand-Displaying Yeast.
    Lown PS; Hackel BJ
    ACS Comb Sci; 2020 May; 22(5):274-284. PubMed ID: 32283920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Titratable Avidity Reduction Enhances Affinity Discrimination in Mammalian Cellular Selections of Yeast-Displayed Ligands.
    Stern LA; Csizmar CM; Woldring DR; Wagner CR; Hackel BJ
    ACS Comb Sci; 2017 May; 19(5):315-323. PubMed ID: 28322543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand Selection by Combination of Recombinant and Cell Panning Selection Techniques.
    Panton RA; Stern LA
    Methods Mol Biol; 2022; 2491():217-233. PubMed ID: 35482193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly avid magnetic bead capture: an efficient selection method for de novo protein engineering utilizing yeast surface display.
    Ackerman M; Levary D; Tobon G; Hackel B; Orcutt KD; Wittrup KD
    Biotechnol Prog; 2009; 25(3):774-83. PubMed ID: 19363813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand Engineering via Yeast Surface Display and Adherent Cell Panning.
    Stern LA; Lown PS; Hackel BJ
    Methods Mol Biol; 2020; 2070():303-320. PubMed ID: 31625103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constrained Combinatorial Libraries of Gp2 Proteins Enhance Discovery of PD-L1 Binders.
    Kruziki MA; Sarma V; Hackel BJ
    ACS Comb Sci; 2018 Jul; 20(7):423-435. PubMed ID: 29799714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Model systems to study the parameters determining the success of phage antibody selections on complex antigens.
    Mutuberria R; Hoogenboom HR; van der Linden E; de Bruïne AP; Roovers RC
    J Immunol Methods; 1999 Dec; 231(1-2):65-81. PubMed ID: 10648928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended yeast surface display linkers enhance the enrichment of ligands in direct mammalian cell selections.
    Lown PS; Cai JJ; Ritter SC; Otolski JJ; Wong R; Hackel BJ
    Protein Eng Des Sel; 2021 Feb; 34():. PubMed ID: 33880560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of Chemically Cyclized Peptide Binders Using Yeast Surface Display.
    Bacon K; Blain A; Burroughs M; McArthur N; Rao BM; Menegatti S
    ACS Comb Sci; 2020 Oct; 22(10):519-532. PubMed ID: 32786323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection and characterization of an HIV-1 gp120-binding affibody ligand.
    Wikman M; Rowcliffe E; Friedman M; Henning P; Lindholm L; Olofsson S; Ståhl S
    Biotechnol Appl Biochem; 2006 Sep; 45(Pt 2):93-105. PubMed ID: 16712522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Target-binding proteins based on the 10th human fibronectin type III domain (¹⁰Fn3).
    Koide S; Koide A; Lipovšek D
    Methods Enzymol; 2012; 503():135-56. PubMed ID: 22230568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a novel strategy for engineering high-affinity proteins by yeast display.
    Richman SA; Healan SJ; Weber KS; Donermeyer DL; Dossett ML; Greenberg PD; Allen PM; Kranz DM
    Protein Eng Des Sel; 2006 Jun; 19(6):255-64. PubMed ID: 16549400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of Single-Domain Antibodies to Transmembrane Proteins Using Magnetized Yeast Cell Targets.
    Bacon K; Menegatti S; Rao BM
    Methods Mol Biol; 2022; 2446():95-119. PubMed ID: 35157270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eradication of Tumors through Simultaneous Ablation of CD276/B7-H3-Positive Tumor Cells and Tumor Vasculature.
    Seaman S; Zhu Z; Saha S; Zhang XM; Yang MY; Hilton MB; Morris K; Szot C; Morris H; Swing DA; Tessarollo L; Smith SW; Degrado S; Borkin D; Jain N; Scheiermann J; Feng Y; Wang Y; Li J; Welsch D; DeCrescenzo G; Chaudhary A; Zudaire E; Klarmann KD; Keller JR; Dimitrov DS; St Croix B
    Cancer Cell; 2017 Apr; 31(4):501-515.e8. PubMed ID: 28399408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A switchable yeast display/secretion system.
    Van Deventer JA; Kelly RL; Rajan S; Wittrup KD; Sidhu SS
    Protein Eng Des Sel; 2015 Oct; 28(10):317-25. PubMed ID: 26333274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autotransporter-Mediated Display of a Naïve Affibody Library on the Outer Membrane of Escherichia coli.
    Andersson KG; Persson J; Ståhl S; Löfblom J
    Biotechnol J; 2019 Apr; 14(4):e1800359. PubMed ID: 30179307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of scFv-displaying yeast in mammalian cell surface selections.
    Wang XX; Shusta EV
    J Immunol Methods; 2005 Sep; 304(1-2):30-42. PubMed ID: 16099466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection and characterization of Affibody ligands binding to Alzheimer amyloid beta peptides.
    Grönwall C; Jonsson A; Lindström S; Gunneriusson E; Ståhl S; Herne N
    J Biotechnol; 2007 Jan; 128(1):162-83. PubMed ID: 17088007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.